Clinical Chemistry, Vol 26, 635-637, Copyright © 1980 by American Association for Clinical Chemistry

Interference of imferon in colorimetric assays for iron

W Huisman

Imferon (Merrell-National), an iron-dextran complex, is widely used in patients with iron deficiency. It is present in the circulation in appreciable amounts for two to three weeks after administration and interferes with all tested colorimetric iron assays, both with and without deproteinization. The amount of the plasma Imferon iron interference depends primarily on the choice of reductant. With dithionite it is essentially 100%. In the presence of ascorbic acid and hydroxylamine, the interference depends also on assay conditions, especially temperature, but also incubation time and pH. The minimum interference in a homogeneous assay was about 3%. The relative amount of interference from hemoglobin iron under the various assay conditions is different from that of Imferon iron. In the presence of a reducing agent, the dextran-iron complex decomposes--instantaneously with dithionite, and gradually with sulfite, ascorbic acid, and hydroxylamine. The freed iron becomes dialyzable, can react with bathophenanthroline, and elutes on a Sephadex G-50 or G-15 column in the same fractions as an ammonium ferrous sulfate.

The following articles in journals at HighWire Press have cited this article:

				D. B. Van Wyck Labile Iron: Manifestations and Clinical Implications J. Am. Soc. Nephrol., December 1, 2004; 15(suppl_2): S107 - S111. [Full Text] [PDF]

				J. Parkkinen, L. von Bonsdorff, S. Peltonen, C. Gronhagen-Riska, and K. Rosenlof Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1827 - 1834. [Abstract] [Full Text] [PDF]